Open an account

Henry Schein

HSIC · NASDAQ

$84.68+$0.71 (+0.85%)TodayMarket closed ·
Prev close $83.97

About HSIC

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 25,000 full-time employees. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products.

Employees
25,000
Headquarters
Melville, New York
Listed
Nov 3, 1995
Sector
Health Care
Industry
Health Care Providers & Services
Website
henryschein.com

HSIC key statistics

Market cap
9.36B
Price-earnings ratio
24.48
Dividend yield
—
Average volume
1.24M
Volume
1.23M
Open price
$84.55
High today
$85.64
Low today
$84.23
52 Week high
$92.18
52 Week low
$62.15

Henry Schein (HSIC) at a glance

Henry Schein (HSIC) last traded at $84.68, with a market cap of 9.36B and a price-to-earnings ratio of 24.48.

Today the stock has traded between $84.23 and $85.64. The current price is 0.5% above the day's low and 1.1% below its high.

Volume so far is 1.23M shares, in line with the average of 1.24M shares a day.

Over the past year Henry Schein has ranged from $62.15 to $92.18, and now sits 75% of the way up that range.

Henry Schein met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $1.27 per share against an estimate of $1.26.

The average analyst price target is $98.74, 16.6% above the current price, from 14 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

57%of 14 analyst ratings say Buy
  • Buy57.1%
  • Hold35.7%
  • Sell7.1%
Price target · 19 analystsAvg $98.74
Low
$64.64
Now
$84.68
High
$115.50

HSIC earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 3.0% on average.

  1. Q3 FY24: reported $1.22 per share against an estimate of $1.19
  2. Q4 FY24: reported $1.19 per share against an estimate of $1.23
  3. Q1 FY25: reported $1.15 per share against an estimate of $1.13
  4. Q2 FY25: reported $1.10 per share against an estimate of $1.22
  5. Q3 FY25: reported $1.38 per share against an estimate of $1.30
  6. Q4 FY25: reported $1.34 per share against an estimate of $1.33
  7. Q1 FY26: reported $1.32 per share against an estimate of $1.24
  8. Q2 FY26: reported $1.27 per share against an estimate of $1.26

HSIC news

  • Press releaseBusiness Wire

    Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET

  • Press releaseBusiness Wire

    Henry Schein Announces Chief Financial Officer Leadership Transition

  • Press releaseBusiness Wire

    Henry Schein Cares Marks 25 Years of Helping Health Happen®

  • Press releaseBusiness Wire

    Henry Schein to Participate in Upcoming Investor Conference in September

  • Press releaseBusiness Wire

    Henry Schein Reports Strong Second Quarter 2026 Financial Results and Raises FY2026 Guidance

  • Press releaseBusiness Wire

    Henry Schein Announces Leadership Transitions

  • Press releaseBusiness Wire

    Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET

  • Press releasePRNewswire

    GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide

Similar companies

Companies in the same industry as Henry Schein

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.